26 results
Keyword Evrenzo Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Evrenzo
Roxadustat, Anemia; Kidney Failure, Chronic
Date of authorisation: 18/08/2021,
, Revision: 2, Authorised, Last updated: 18/10/2022
Evrenzo Hemic and Lymphatic Diseases Hematologic … thorised roxadustat Overview Evrenzo is a medicine used in adults … kidneys to work properly). Evrenzo contains the The substance … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 June 2021
CHMP, Last updated: 25/06/2021Evrenzo … -
List item
Human medicine European public assessment report (EPAR): Vafseo (new)
Vadadustat, Renal Insufficiency, Chronic; Anemia
Date of authorisation: 24/04/2023,, Authorised, Last updated: 31/05/2023
-
List item
List of medicines under additional monitoring (updated)
Last updated: 30/05/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-7 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 04/07/2022 to 07/07/2022, Last updated: 31/03/2023 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/01/2022 to 13/01/2022, Last updated: 07/10/202215 4.1.3. Roxadustat – EVRENZO (CAP … -
List item
Newsletters (updated)
Last updated: 30/05/2023 -
List item
PRAC: Agendas, minutes and highlights (updated)
Last updated: 07/06/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 May 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/05/2022 to 19/05/2022, Last updated: 12/08/2022 -
List item
Download medicine data
Last updated: 02/12/2021 -
List item
CHMP: Agendas, minutes and highlights (updated)
Last updated: 06/06/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 18/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 21/06/2021 to 24/06/2021, Last updated: 07/12/202112 3.1.5. Evrenzo - roxadustat - EMEA/H/C/004871 … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 July 2022
PRAC, Last updated: 08/07/2022 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 9-12 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 09/01/2023 to 12/01/2023, Last updated: 18/08/2021 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022
PRAC, Last updated: 14/01/202215 4.1.3. Roxadustat – EVRENZO (CAP … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 - 12 January 2023
PRAC, Last updated: 13/01/2023 -
List item
News: Human medicines: highlights of 2021
Last updated: 15/02/2022Okedi Psychiatry Vaccines Apexxnar Vaxneuvance Haematology/ Haemostaseology Aspaveli Brukinsa Copiktra Evrenzo Minjuvi Onureg Oxbryta Thiotepa … -
List item
Annual reports and work programmes (updated)
Last updated: 15/05/2023 -
List item
EMA event supporting materials
Last updated: 14/06/2022 -
List item
Leaflets
Last updated: 23/09/2016Okedi Psychiatry Vaccines Apexxnar Vaxneuvance Haematology/ Haemostaseology Aspaveli Brukinsa Copiktra Evrenzo Minjuvi Onureg Oxbryta Thiotepa …
-
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 19/07/2021 to 22/07/2021, Last updated: 07/10/2021 -
List item
News: EMA publishes annual report 2021
Last updated: 10/06/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 July 2022
European Medicines Agency, Amsterdam, the Netherlands, from 18/07/2022 to 21/07/2022, Last updated: 06/04/2021 -
List item
Public data from Article 57 database
Last updated: 17/10/2022